Systemic sclerosis in an Afro-Caribbean population: A review of demographic and clinical features

West Indian Medical Journal

Volumn 57, Issue 2, 2008, Pages 118-121

  Flower, C ^a   Nwankwo, C ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN CARIBBEAN; BARBADOS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; FREQUENCY ANALYSIS; GASTROESOPHAGEAL REFLUX; GENDER BIAS; HUMAN; INCIDENCE; LUNG DISEASE; MALE; MEDICAL RECORD REVIEW; ONSET AGE; PIGMENT DISORDER; PREVALENCE; RAYNAUD PHENOMENON; REVIEW; SKIN MANIFESTATION; SKIN ULCER; SYSTEMIC SCLEROSIS; TELANGIECTASIA;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BARBADOS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 48449102706     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Reveille JD. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics and clinical manifestations. Curr Rheumatol Rep 2003; 5: 160-7.
2. Tormey VJ, Bunn CC, Denton CP, Black CM. Anti-fibrillarin anti-bodies in systemic sclerosis. Rheumatology 2001; 40: 1157-62.
3. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23: 581-90.
4. Rodnan GP, Benedek TG An historical account of the study of progressive systemic sclerosis (diffuse scleroderma) Ann Intern Med 1962; 57: 305-19.
5. Sakkas LL New developments in the pathogenesis of systemic sclerosis. Autoimmunity 2005; 38: 113-6.
6. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246-55.
7. Nietert PJ, Mitchell HC, Bolster MB, Shaftman SR, Tilley BC, Silver RM. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 2006; 33: 263-8.
8. Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum. 2001; 30: 332-46.
9. Sunderkotter C, Riemekasten G. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis. Rheumatol 2006; 45: S3 33-5.
10. Anderson ME, Moore TL, Lunt M, Herrick AL. The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon. Rheumatol 2007; 46: 533-8.
11. Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA. Esophageal involvement in scleroderma: Gastroesophageal reflux the common problem. Semin Arthritis Rheum 2006; 36: 173-81.
12. Chung L, Fiorentino D. Digital ulcers in patients with systemic sclerosis. Autoimmun Rev 2006; 5: 125-8.
13. Walker JQ Sterling J, Beroukas D. Histopathological and ultrastructural features of dermal telangiectasia in systemic sclerosis. Pathology 2005; 37: 220-5.
14. Sparsa A, Lesaux N, Kessler E, Bonnetblanc JM, Blaise S, Lebrun-Ly V et al. Treatment of cutaneous calcinosis in CREST syndrome by extracorporeal shock wave lithotripsy. J Am Acad Dermatol 2005; 53: S263-5.
15. Chamberlain AJ, Walker NP. Successful palliation and significant remission of cutaneous calcinosis in CREST syndrome with carbon dioxide laser. Dermatol Surg. 2003; 29: 968-70.
16. Mayes MD. Race, scleroderma, and survival: Why is there a difference. J Rheumatol 2005; 32: 1873-4.